BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36340715)

  • 1. A novel mutation in ryanodine receptor 2 (
    Hu J; Gao X; Chen L; Zhou T; Du Z; Jiang J; Wei L; Zhang Z
    Front Pediatr; 2022; 10():1022268. PubMed ID: 36340715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ryanodine receptor 2 (RYR2) mutation: A potentially novel neurocardiac calcium channelopathy manifesting as primary generalised epilepsy.
    Yap SM; Smyth S
    Seizure; 2019 Apr; 67():11-14. PubMed ID: 30849713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report.
    Seidlmayer LK; Riediger F; Pagonas N; Nordbeck P; Ritter O; Sasko B
    J Med Case Rep; 2018 Oct; 12(1):298. PubMed ID: 30296944
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Ma MG; Liu XR; Wu Y; Wang J; Li BM; Shi YW; Su T; Li B; Liu DT; Yi YH; Liao WP
    Front Neurosci; 2021; 15():629610. PubMed ID: 33897349
    [No Abstract]   [Full Text] [Related]  

  • 5. Bradycardia Is a Specific Phenotype of Catecholaminergic Polymorphic Ventricular Tachycardia Induced by RYR2 Mutations.
    Miyata K; Ohno S; Itoh H; Horie M
    Intern Med; 2018 Jul; 57(13):1813-1817. PubMed ID: 29434162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel exon3 deletion of RYR2 in a family with catecholaminergic polymorphic ventricular tachycardia.
    Dharmawan T; Nakajima T; Ohno S; Iizuka T; Tamura S; Kaneko Y; Horie M; Kurabayashi M
    Ann Noninvasive Electrocardiol; 2019 May; 24(3):e12623. PubMed ID: 30615235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare RYR2 p.Thr85Ile variant is associated with catecholaminergic polymorphic ventricular tachycardia.
    Kohli U; Hassan RS; Lawrence DK
    J Electrocardiol; 2020; 62():134-137. PubMed ID: 32866913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.
    Priori SG; Napolitano C; Memmi M; Colombi B; Drago F; Gasparini M; DeSimone L; Coltorti F; Bloise R; Keegan R; Cruz Filho FE; Vignati G; Benatar A; DeLogu A
    Circulation; 2002 Jul; 106(1):69-74. PubMed ID: 12093772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and genetic analysis of five children with Catecholaminergic polymorphic ventricular tachycardia due to variants of RYR2 gene].
    Sun Q; Wang F; Zheng R; Xie Z; Jia L; Li D
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Aug; 40(8):960-965. PubMed ID: 37532495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel variant in RyR2 causes familiar catecholaminergic polymorphic ventricular tachycardia.
    Bosch C; Campuzano O; Sarquella-Brugada G; Cesar S; Perez-Serra A; Coll M; Mademont I; Mates J; Del Olmo B; Iglesias A; Brugada J; Petersen V; Brugada R
    Forensic Sci Int; 2017 Jan; 270():173-177. PubMed ID: 27988446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives.
    van der Werf C; Nederend I; Hofman N; van Geloven N; Ebink C; Frohn-Mulder IM; Alings AM; Bosker HA; Bracke FA; van den Heuvel F; Waalewijn RA; Bikker H; van Tintelen JP; Bhuiyan ZA; van den Berg MP; Wilde AA
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):748-56. PubMed ID: 22787013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification and correlation of RYR2 missense variants in individuals with catecholaminergic polymorphic ventricular tachycardia reveals phenotypic relationships.
    Olubando D; Hopton C; Eden J; Caswell R; Lowri Thomas N; Roberts SA; Morris-Rosendahl D; Venetucci L; Newman WG
    J Hum Genet; 2020 Jun; 65(6):531-539. PubMed ID: 32152366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac arrest in a mother and daughter and the identification of a novel RYR2 variant, predisposing to low penetrant catecholaminergic polymorphic ventricular tachycardia in a four-generation Canadian family.
    Tung M; Van Petegem F; Lauson S; Collier A; Hodgkinson K; Fernandez B; Connors S; Leather R; Sanatani S; Arbour L
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1151. PubMed ID: 31994352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sudden death after inappropriate shocks of implantable cardioverter defibrillator in a catecholaminergic polymorphic ventricular tachycardia case with a novel RyR2 mutation.
    Itoh H; Murayama T; Kurebayashi N; Ohno S; Kobayashi T; Fujii Y; Watanabe M; Ogawa H; Anzai T; Horie M
    J Electrocardiol; 2021; 69():111-118. PubMed ID: 34656916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-exome sequencing in familial type 2 diabetes identifies an atypical missense variant in the RyR2 gene.
    Bansal V; Winkelmann BR; Dietrich JW; Boehm BO
    Front Endocrinol (Lausanne); 2024; 15():1258982. PubMed ID: 38444585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a novel mutation in the cardiac ryanodine receptor that results in catecholaminergic polymorphic ventricular tachycardia.
    Jiang D; Jones PP; Davis DR; Gow R; Green MS; Birnie DH; Chen SR; Gollob MH
    Channels (Austin); 2010; 4(4):302-10. PubMed ID: 20676041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss-of-function mutations in cardiac ryanodine receptor channel cause various types of arrhythmias including long QT syndrome.
    Hirose S; Murayama T; Tetsuo N; Hoshiai M; Kise H; Yoshinaga M; Aoki H; Fukuyama M; Wuriyanghai Y; Wada Y; Kato K; Makiyama T; Kimura T; Sakurai T; Horie M; Kurebayashi N; Ohno S
    Europace; 2022 Mar; 24(3):497-510. PubMed ID: 34661651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Search for cardiac calcium cycling gene mutations in familial ventricular arrhythmias resembling catecholaminergic polymorphic ventricular tachycardia.
    Marjamaa A; Laitinen-Forsblom P; Lahtinen AM; Viitasalo M; Toivonen L; Kontula K; Swan H
    BMC Med Genet; 2009 Feb; 10():12. PubMed ID: 19216760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel RYR2 loss-of-function mutation (I4855M) is associated with left ventricular non-compaction and atypical catecholaminergic polymorphic ventricular tachycardia.
    Roston TM; Guo W; Krahn AD; Wang R; Van Petegem F; Sanatani S; Chen SR; Lehman A
    J Electrocardiol; 2017; 50(2):227-233. PubMed ID: 27646203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice.
    Lehnart SE; Mongillo M; Bellinger A; Lindegger N; Chen BX; Hsueh W; Reiken S; Wronska A; Drew LJ; Ward CW; Lederer WJ; Kass RS; Morley G; Marks AR
    J Clin Invest; 2008 Jun; 118(6):2230-45. PubMed ID: 18483626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.